LINEAGE CELL THERAPEUTICS IN's ticker is and the CUSIP is 53566P909. A total of 3 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 200 | -99.3% | 0.00% | – |
| Q1 2023 | $42 | -2.3% | 28,600 | -23.9% | 0.00% | – |
| Q4 2022 | $43 | -99.8% | 37,600 | +54.1% | 0.00% | – |
| Q3 2022 | $27,000 | +107.7% | 24,400 | +183.7% | 0.00% | – |
| Q2 2022 | $13,000 | +85.7% | 8,600 | +75.5% | 0.00% | – |
| Q1 2022 | $7,000 | -96.5% | 4,900 | -94.0% | 0.00% | – |
| Q4 2021 | $199,000 | +201.5% | 81,600 | +248.7% | 0.00% | – |
| Q3 2021 | $66,000 | 0.0% | 23,400 | +0.4% | 0.00% | – |
| Q2 2021 | $66,000 | +135.7% | 23,300 | +18843.1% | 0.00% | – |
| Q1 2021 | $28,000 | -86.0% | 123 | -89.2% | 0.00% | – |
| Q4 2020 | $200,000 | +2122.2% | 1,140 | +1063.3% | 0.00% | – |
| Q3 2020 | $9,000 | -50.0% | 98 | -53.8% | 0.00% | – |
| Q2 2020 | $18,000 | -59.1% | 212 | -60.2% | 0.00% | – |
| Q1 2020 | $44,000 | +4300.0% | 533 | +2861.1% | 0.00% | – |
| Q3 2019 | $1,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 4,900 | $7,350 | 0.00% |
| SIMPLEX TRADING, LLC | 28,600 | $42 | 0.00% |